POEMS syndrome: update on diagnosis, risk-stratification, and management

American Journal of Hematology
Angela Dispenzieri

Abstract

POEMS syndrome is a paraneoplastic syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease. Minor features include organomegaly, endocrinopathy, characteristic skin changes, papilledema, extravascular volume overload, and thrombocytosis. Diagnoses are often delayed because the syndrome is rare and can be mistaken for other neurologic disorders, most commonly chronic inflammatory demyelinating polyradiculoneuropathy. POEMS syndrome should be distinguished from the Castleman disease variant of POEMS syndrome, which has no clonal PCD and typically little to no peripheral neuropathy but has several of the minor diagnostic criteria for POEMS syndrome. The diagnosis of POEMS syndrome is made with three of the major criteria, two of which must include polyradiculoneuropathy and clonal plasma cell disorder, and at least one of the minor criteria. Because the pathogenesis of the syndrome is not well understood, risk stratification is limited to clinical phenotype rather than specific molecular markers. The number of clinical criteria is n...Continue Reading

References

Jul 1, 1976·American Journal of Clinical Pathology·G S Yu, J W Carson
Jan 1, 1978·American Journal of Clinical Pathology·A R GabaD Variakojis
Jan 1, 1992·Clinical Neurology and Neurosurgery·C CrisciG Caruso
Jan 1, 1991·Japanese Journal of Medicine·S ShirabeK Tobinaga
Jan 1, 1991·Nephron·S MizuiriS Kawamura
Aug 1, 1991·Australian and New Zealand Journal of Medicine·J Bosco, R Pathmanathan
Mar 15, 1991·Annals of Internal Medicine·R K GherardiJ D Degos
Nov 1, 1990·Survey of Ophthalmology·P W BrazisR M Burde
Aug 1, 1990·Histopathology·G MunozM A Piris
Jan 1, 1989·Gastroenterology·J M LoebA D Cooper
Feb 1, 1989·Journal of the Neurological Sciences·M DonaghyP K Thomas
Oct 1, 1989·Scottish Medical Journal·P M StewartC R Edwards
Oct 1, 1987·The British Journal of Dermatology·O IshikawaH Ishikawa
Jan 1, 1988·Virchows Archiv. A, Pathological Anatomy and Histopathology·R GherardiJ Poirier
Jan 1, 1987·European Neurology·F X BergouignanC Effroy
Jan 1, 1986·Virchows Archiv. A, Pathological Anatomy and Histopathology·M SanoS Tojo
Mar 1, 1988·Postgraduate Medical Journal·D A BlackR P Thompson
Oct 1, 1985·The American Journal of Surgical Pathology·H KobayashiF Ogushi
Dec 1, 1972·Archives of Neurology·L E Davis, D B Drachman
Oct 1, 1967·Journal of Neurology, Neurosurgery, and Psychiatry·J B Morley, A C Schwieger
Jan 1, 1980·Acta Medica Scandinavica·J B ReitanO P Solheim
Feb 1, 1983·Neurology·J J KellyP J Dyck
Jun 1, 1984·Neurology·T NakanishiY Ozaki
Jul 1, 1995·Archives of Physical Medicine and Rehabilitation·A KuW Nagler
Oct 1, 1994·Italian Journal of Neurological Sciences·D PareysonA Sghirlanzoni
Dec 1, 1994·Neurological Research·G OreficeF Barbieri
Dec 1, 1994·The American Journal of Medicine·M J SoubrierB J Sauvezie
Apr 1, 1994·The American Journal of Dermatopathology·F RongiolettiR Lerza
Feb 1, 1994·The American Journal of the Medical Sciences·H M AdelmanP M Wallach
Jul 1, 1993·Clinical and Experimental Dermatology·M R JudgeR P Thompson

❮ Previous
Next ❯

Citations

Nov 17, 2015·Expert Opinion on Pharmacotherapy·Paola Marmiroli, Guido Cavaletti
Jan 11, 2016·Revista clínica española·A González GarcíaJ L Patier de la Peña
Jul 2, 2016·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·A BirkenbachM A Gamulescu
Jul 29, 2016·The New England Journal of Medicine·Stephanie A MooreJames R Stone
Aug 9, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·D Lipsker
Sep 23, 2016·Journal of the Neurological Sciences·Ahmed AbbasYusuf A Rajabally
Aug 18, 2016·Journal of Cutaneous Pathology·Franco RongiolettiCaterina Ferreli
Jun 2, 2017·Continuum : Lifelong Learning in Neurology·Michelle L Mauermann
May 13, 2017·Annales d'endocrinologie·Maud MarchandCarine Courtillot
Oct 20, 2017·British Journal of Haematology·Andrea NozzaEduardo Nobile-Orazio
Jul 18, 2018·American Journal of Hematology·Chika Kawajiri-ManakoChiaki Nakaseko
Jun 24, 2017·BMJ Case Reports·Omar Al-MayoofMaria Khan
Mar 6, 2016·Pain·Siddarth ThakurDavid N Herrmann
Mar 17, 2017·Current Hematologic Malignancy Reports·Rahma WarsamePrashant Kapoor
Mar 28, 2017·Skeletal Radiology·Michael S ClarkStephen M Broski
Sep 28, 2017·Cancers·John NearyManuela G Neuman
Apr 4, 2019·Frontiers in Neurology·Khidhir KamilJaya Kumar
Feb 9, 2017·Journal of Clinical Neurology·Zigao WangHengbing Zu
Apr 12, 2017·Hematological Oncology·Evan RosenbaumShahzad Raza
Nov 1, 2017·QJM : Monthly Journal of the Association of Physicians·V GremainV Langlois
Jan 13, 2019·Leukemia·Yuhei NagaoChiaki Nakaseko
Nov 17, 2020·Frontiers in Endocrinology·Hongbo YangJian Li
Apr 7, 2021·The Journal of International Medical Research·Hua Ping DuLiang Luo
Feb 8, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Chika Kawajiri-ManakoChiaki Nakaseko
Aug 16, 2021·Blood Cancer Journal·Yan-Ying YuJian Li
Nov 10, 2017·British Journal of Anaesthesia·M Brown, P Farquhar-Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis